Galderma Investigational Site 8030

Raleigh, North Carolina 27612

0 studies enrolling now · 1 studies all time

What they study most

Moderate-to-Severe Atopic Dermatitis

Studies at this site

• Efficacy & Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis — Completed